Novo Holdings is a Danish holding and investment company that manages the assets of the Novo Nordisk Foundation, one of the world’s largest enterprise foundations. Established in 1999, Novo Holdings oversees a diverse portfolio with a strong emphasis on life sciences, including investments in biotechnology, pharmaceuticals, and medical devices. As of 2023, the company manages approximately €149 billion in assets.